JP2014201568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014201568A5 JP2014201568A5 JP2013080907A JP2013080907A JP2014201568A5 JP 2014201568 A5 JP2014201568 A5 JP 2014201568A5 JP 2013080907 A JP2013080907 A JP 2013080907A JP 2013080907 A JP2013080907 A JP 2013080907A JP 2014201568 A5 JP2014201568 A5 JP 2014201568A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- active ingredient
- prickly pear
- food composition
- ameliorating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000001439 Opuntia Species 0.000 claims 16
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 claims 16
- 239000004480 active ingredient Substances 0.000 claims 16
- 235000013305 food Nutrition 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 230000028327 secretion Effects 0.000 claims 4
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims 2
- 102000051325 Glucagon Human genes 0.000 claims 2
- 108060003199 Glucagon Proteins 0.000 claims 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 102100040918 Pro-glucagon Human genes 0.000 claims 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 2
- 230000006866 deterioration Effects 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims 2
- 229960004666 glucagon Drugs 0.000 claims 2
- 230000004217 heart function Effects 0.000 claims 2
- 201000001421 hyperglycemia Diseases 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 239000002830 appetite depressant Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013080907A JP2014201568A (ja) | 2013-04-09 | 2013-04-09 | Glp−1分泌促進剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013080907A JP2014201568A (ja) | 2013-04-09 | 2013-04-09 | Glp−1分泌促進剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014201568A JP2014201568A (ja) | 2014-10-27 |
| JP2014201568A5 true JP2014201568A5 (enExample) | 2016-07-07 |
Family
ID=52352331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013080907A Pending JP2014201568A (ja) | 2013-04-09 | 2013-04-09 | Glp−1分泌促進剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2014201568A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112569219B (zh) * | 2019-09-30 | 2023-05-02 | 中国科学院上海药物研究所 | 用于治疗动脉相关疾病的药物及其用途 |
-
2013
- 2013-04-09 JP JP2013080907A patent/JP2014201568A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY188344A (en) | Extract formulations of rhodamnia cinerea and uses thereof | |
| MX391293B (es) | DERIVADOs DE OXINTOMODULINA NOVEDOSOS Y COMPOSICION FARMACEUTICA PARA TRATAR LA OBESIDAD QUE COMPRENDE LOS MISMOS. | |
| HK1213483A1 (zh) | Glp1/gip双重激动剂或glp1/gip/胰高血糖素三重激动剂 | |
| PH12017501079A1 (en) | 1,3-thiazol-2-yl substituted benzamides | |
| WO2017009236A3 (en) | New exendin-4 derivatives as selective peptidic dual glp-1 / glucagon receptor agonists | |
| MA40466A (fr) | Utilisation d'agoniste double de récepteur de glp-1/glucagon à action prolongée permettant le traitement de stéatose hépatique non-alcoolique | |
| PH12015500688A1 (en) | Exendin-4 derivatives as dual glp1/glucagon agonists | |
| HK1207097A1 (en) | Fusion proteins for treating a metabolic syndrome | |
| MX2016013244A (es) | Derivados de exendina-4 como agonistas peptidicos duales del receptor de glp-1/glucagon. | |
| MX2016013248A (es) | Agonistas duales del receptor de glp-1/glucagon derivados de exendina-4. | |
| CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
| TN2018000452A1 (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
| PH12018500261B1 (en) | Azole benzene derivative | |
| WO2010087565A3 (ko) | 피페린의 신규한 용도 | |
| TN2018000038A1 (en) | Inhibitor of the mutated isocitrate dehydrogenase idh1 r132h | |
| MX2012006734A (es) | Tiazolidinadionas moderadoras de receptores activados por proliferador de peroxisoma (ppar) y combinaciones para el tratamiento de obesidad y otras enfermedades metabolicas. | |
| PH12014502802B1 (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
| PH12017501205A1 (en) | Glucagon derivatives | |
| JP2014201568A5 (enExample) | ||
| WO2015042495A3 (en) | Metformin salts to treat type2 diabetes | |
| WO2011111066A3 (en) | Composition and uses thereof | |
| JP2014201567A5 (enExample) | ||
| MX346646B (es) | Formulacion farmaceutica de decavanadato de 4-dimetilaminopiridini o y sus derivados, para la prevencion y tratamiento del sindrome metabolico, obesidad y diabetes tipo 2. | |
| UA114792C2 (uk) | Коагоніст глюкагонового рецептора/glp-1-рецептора | |
| MX2015009557A (es) | Uso insulinomimetico de compuestos no-peptidicos con vanadio y sus derivados. |